Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
Potassium chloride; Sodium chloride; Glucose monohydrate
Baxter Holding B.V.
B05BB; B05BB02
Potassium chloride; Sodium chloride; Glucose monohydrate
0.3/0.18/4 percent weight/volume
Solution for infusion
Solutions affecting the electrolyte balance; electrolytes with carbohydrates
Marketed
2008-04-11
PACKAGE LEAFLET: INFORMATION FOR THE USER POTASSIUM CHLORIDE 0.3% W/V AND SODIUM CHLORIDE 0.18% W/V IN 4% W/V GLUCOSE INTRAVENOUS INFUSION BP (VIAFLO CONTAINER) Active substances: potassium chloride, sodium chloride and glucose monohydrate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or nurse. • If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. Throughout this leaflet, Potassium Chloride 0.3% w/v, Sodium Chloride 0.18% w/v and Glucose 4% w/v, Solution for Infusion will be called Potassium chloride, Sodium chloride & Glucose Infusion WHAT IS IN THIS LEAFLET: 1. What Potassium chloride, Sodium chloride & Glucose Infusion is and what it is used for 2. What you need to know before you are given Potassium chloride, Sodium chloride & Glucose Infusion 3. How you will be given Potassium chloride, Sodium chloride & Glucose Infusion 4. Possible side effects 5. How to store Potassium chloride, Sodium chloride & Glucose Infusion 6. Content of the pack and other information 1. WHAT POTASSIUM CHLORIDE, SODIUM CHLORIDE & GLUCOSE INFUSION IS AND WHAT IT IS USED FOR Potassium chloride, Sodium chloride & Glucose Infusion is a solution of potassium chloride, sodium chloride and glucose monohydrate in water. Potassium chloride and sodium chloride are chemicals (often called “salts”) found in the blood. It is used to prevent and treat the following conditions: • if you do not have enough potassium, sodium and chloride in your blood. This can occur when gastrointestinal (stomach) fluid is lost. This can happen if: – you have vomiting – you have diarrhoea – a wound is drained after surgery (by collecting body fluid in a bag) – you have gastric (stomach) suction to empty the stomach contents – part of your digestive system has been diverted so that food does not Lue koko asiakirja
Health Products Regulatory Authority 10 August 2020 CRN008ZC3 Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Potassium Chloride 0.3% w/v and Sodium Chloride 0.18% w/v in Glucose 4% w/v Intravenous Infusion BP (Viaflo Container) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active Substances: Potassium Chloride 0.30 % w/v Sodium Chloride 0.18 % w/v Glucose Monohydrate 4.4 % w/v _(equivalent to anhydrous glucose 4.0% w/v)_ Equivalent to: mmol/L Potassium 40 Sodium 30 Chloride 70 For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Clear, colourless solution, free from visible particles. pH: 3.5 – 5.5 Osmolarity: 362 mOsm/l 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prevention and treatment of potassium, sodium and chloride depletion due to a loss of gastrointestinal fluid (vomiting, diarrhoea, surgical drainage, gastric suction, small intestinal bypass procedure, or small bowel fistula), a chronic abuse of laxative, malabsorption syndromes, mucus secreting villous adenoma of the small intestine, or renal salt-losing conditions (renal disorders, overuse of diuretics), particularly in cases (e.g. starvation) where a source of energy is required. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _ _ _Adults, the Elderly and Children_ The choice of the specific potassium chloride, sodium chloride, and glucose concentration, dosage, volume, rate and duration of administration depends on the age, weight and clinical condition of the patient and concomitant therapy, and administration should be determined by a physician. For patients with electrolyte and glucose abnormalities and for paediatric patients, consult a physician experienced in intravenous fluid therapy. Fluid balance, serum glucose, serum sodium and other electrolytes should be monitored before and during administration, especially in patients with increased non-osmotic vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medic Lue koko asiakirja